{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:33:27Z","timestamp":1791232407496,"version":"4.1.0"},"reference-count":50,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2023,10,3]]},"abstract":"<jats:p>Background: To date, it is still controversial whether tau phosphorylation plays a role in Huntington\u2019s disease (HD), as previous studies demonstrated either no alterations or increases in phosphorylated tau (pTau) in HD postmortem brain and mouse models. Objective: The goal of this study was to determine whether total tau and pTau levels are altered in HD. Methods: Immunohistochemistry, cellular fractionations, and western blots were used to measure total tau and pTau levels in a large cohort of HD and control postmortem prefrontal cortex (PFC). Furthermore, western blots were performed to assess tau, and pTau levels in HD and control isogenic embryonic stem cell (ESC)-derived cortical neurons and neuronal stem cells (NSCs). Similarly, western blots were used to assess tau and pTau levels in HttQ111 and transgenic R6\/2 mice. Lastly, total tau levels were assessed in HD and healthy control plasma using Quanterix Simoa assay. Results: Our results revealed that, while there was no difference in total tau or pTau levels in HD PFC compared to controls, the levels of tau phosphorylated at S396 were increased in PFC samples from HD patients 60 years or older at time of death. Additionally, tau and pTau levels were not changed in HD ESC-derived cortical neurons and NSCs. Similarly, total tau or pTau levels were not altered in HttQ111 and transgenic R6\/2 mice compared to wild-type littermates. Lastly, tau levels were not changed in plasma from a small cohort of HD patients compared to controls. Conclusions: Together these findings demonstrate that pTau-S396 levels increase significantly with age in HD PFC.<\/jats:p>","DOI":"10.3233\/jhd-230588","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T11:51:50Z","timestamp":1693914710000},"page":"267-281","source":"Crossref","is-referenced-by-count":11,"title":["Age-Dependent Increase in Tau Phosphorylation at Serine 396 in Huntington\u2019s Disease Prefrontal Cortex"],"prefix":"10.1177","volume":"12","author":[{"given":"Tiziana","family":"Petrozziello","sequence":"first","affiliation":[{"name":"Sean M. Healey & AMG Center for ALS at Mass General, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sommer S.","family":"Huntress","sequence":"additional","affiliation":[{"name":"Sean M. Healey & AMG Center for ALS at Mass General, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayleen L.","family":"Castillo-Torres","sequence":"additional","affiliation":[{"name":"Sean M. Healey & AMG Center for ALS at Mass General, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa R.","family":"Connors","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne A.","family":"Auger","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra N.","family":"Mills","sequence":"additional","affiliation":[{"name":"Sean M. Healey & AMG Center for ALS at Mass General, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer E.","family":"Kim","sequence":"additional","affiliation":[{"name":"Sean M. Healey & AMG Center for ALS at Mass General, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Boudi","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzhou","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sapp","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Kivis\u00e4kk","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekar R.","family":"Sunderesh","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Pouladi","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, British Columbia Children\u2019s Hospital Research Institute, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Hyman","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Diana","family":"Rosas","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"DiFiglia","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Mouro Pinto","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"},{"name":"Center for Genomic Medicine, MassGeneral Brigham, Boston, MA, USA"},{"name":"Department of Neurology, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Kegel-Gleason","sequence":"additional","affiliation":[{"name":"Department of Neurology, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Sadri-Vakili","sequence":"additional","affiliation":[{"name":"Sean M. Healey & AMG Center for ALS at Mass General, MassGeneral Brigham, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-230588_ref1","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72(6):971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"issue":"4","key":"10.3233\/JHD-230588_ref2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: Natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.3233\/JHD-230588_ref3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","article-title":"Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease","volume":"135","author":"St-Amour","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"Pt 7","key":"10.3233\/JHD-230588_ref4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awv107","article-title":"The role of tau in the pathological process and clinical expression of Huntington\u2019s disease","volume":"138","author":"Vuono","year":"2015","journal-title":"Brain"},{"issue":"8","key":"10.3233\/JHD-230588_ref5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nm.3617","article-title":"Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods","volume":"20","author":"Fernandez-Nogales","year":"2014","journal-title":"Nat Med"},{"key":"10.3233\/JHD-230588_ref6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-981-32-9358-8_7","article-title":"Tau and axonal transport misregulation in tauopathies","volume":"1184","author":"Combs","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JHD-230588_ref7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","article-title":"Molecular pathogenesis of the tauopathies","volume":"14","author":"Gotz","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.3233\/JHD-230588_ref8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JHD-230588_ref9","first-page":"796024","article-title":"The role of tau in neurodegenerative diseases and its potential as a therapeutic target","volume":"2012","author":"Wolfe","year":"2012","journal-title":"Scientifica (Cairo)"},{"issue":"6","key":"10.3233\/JHD-230588_ref10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.3233\/JHD-230588_ref11","first-page":"1141","article-title":"Tau protein in neurodegenerative diseases - a review","volume":"58","author":"Pirscoveanu","year":"2017","journal-title":"Rom J Morphol Embryol"},{"key":"10.3233\/JHD-230588_ref12","doi-asserted-by":"crossref","first-page":"689332","DOI":"10.3389\/fncel.2021.689332","article-title":"Huntingtin and the synapse","volume":"15","author":"Barron","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JHD-230588_ref13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.conb.2020.04.001","article-title":"Traffic signaling: New functions of huntingtin and axonal transport in neurological disease","volume":"63","author":"Vitet","year":"2020","journal-title":"Curr Opin Neurobiol"},{"issue":"7","key":"10.3233\/JHD-230588_ref14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41374-018-0166-9","article-title":"Spectrum of tau pathologies in Huntington\u2019s disease","volume":"99","author":"Baskota","year":"2019","journal-title":"Lab Invest"},{"issue":"9","key":"10.3233\/JHD-230588_ref15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","article-title":"Identification of genetic variants associated with Huntington\u2019s disease progression: A genome-wide association study","volume":"16","author":"Moss","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-230588_ref16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fncel.2019.00574","article-title":"Altered levels and isoforms of tau and nuclear membrane invaginations in Huntington\u2019s disease","volume":"13","author":"Fernandez-Nogales","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"10.3233\/JHD-230588_ref17","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/brain\/awx255","article-title":"Presence of tau pathology within foetal neural allografts in patients with Huntington\u2019s and Parkinson\u2019s disease","volume":"140","author":"Cisbani","year":"2017","journal-title":"Brain"},{"issue":"6","key":"10.3233\/JHD-230588_ref18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jnnp.48.6.530","article-title":"Late onset of Huntington\u2019s disease","volume":"48","author":"Myers","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.3233\/JHD-230588_ref19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.35.2.273","article-title":"Dementia of the Alzheimer\u2019s type and Huntington\u2019s disease","volume":"35","author":"Reyes","year":"1985","journal-title":"Neurology"},{"issue":"6","key":"10.3233\/JHD-230588_ref20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ana.410030616","article-title":"Huntington disease associated with Alzheimer disease","volume":"3","author":"McIntosh","year":"1978","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JHD-230588_ref21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/exnr.1998.6778","article-title":"Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington\u2019s, Alzheimer\u2019s, and Pick\u2019s diseases","volume":"150","author":"Singhrao","year":"1998","journal-title":"Exp Neurol"},{"issue":"1","key":"10.3233\/JHD-230588_ref22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jnc.13719","article-title":"Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington\u2019s disease","volume":"139","author":"Rodrigues","year":"2016","journal-title":"J Neurochem"},{"issue":"9","key":"10.3233\/JHD-230588_ref23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.parkreldis.2011.06.010","article-title":"Increased levels of total tau protein in the cerebrospinal fluid in Huntington\u2019s disease","volume":"17","author":"Constantinescu","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.3233\/JHD-230588_ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-160196","article-title":"Cerebrospinal fluid biomarkers for Huntington\u2019sdisease","volume":"5","author":"Byrne","year":"2016","journal-title":"J Huntingtons Dis"},{"issue":"5","key":"10.3233\/JHD-230588_ref25","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J Clin Invest"},{"issue":"2","key":"10.3233\/JHD-230588_ref26","doi-asserted-by":"crossref","first-page":"e13035","DOI":"10.1111\/bpa.13035","article-title":"Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid","volume":"32","author":"Petrozziello","year":"2022","journal-title":"Brain Pathol"},{"key":"10.3233\/JHD-230588_ref27","doi-asserted-by":"crossref","first-page":"105032","DOI":"10.1016\/j.nbd.2020.105032","article-title":"Neuroinflammation and histone H3 citrullination are increased in X-linked dystonia parkinsonism post-mortem prefrontal cortex","volume":"144","author":"Petrozziello","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.3233\/JHD-230588_ref28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mus.26911","article-title":"Lipocalin-2 is increased in amyotrophic lateral sclerosis","volume":"62","author":"Petrozziello","year":"2020","journal-title":"Muscle Nerve"},{"issue":"22","key":"10.3233\/JHD-230588_ref29","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1093\/hmg\/ddv351","article-title":"The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: Implications of prion-like properties","volume":"24","author":"Matsumoto","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.3233\/JHD-230588_ref30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s12035-021-02557-w","article-title":"Targeting tau mitigates mitochondrial fragmentation and oxidative stress in amyotrophic lateral sclerosis","volume":"59","author":"Petrozziello","year":"2022","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.3233\/JHD-230588_ref31","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","article-title":"The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system","volume":"181","author":"Tai","year":"2012","journal-title":"Am J Pathol"},{"issue":"9","key":"10.3233\/JHD-230588_ref32","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.celrep.2019.02.008","article-title":"Unbiased profiling of isogenic Huntington disease hPSC-derived CNS and peripheral cells reveals strong cell-type specificity of CAG length effects","volume":"26","author":"Ooi","year":"2019","journal-title":"Cell Rep"},{"issue":"23","key":"10.3233\/JHD-230588_ref33","doi-asserted-by":"crossref","first-page":"E4676","DOI":"10.1073\/pnas.1614943114","article-title":"KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington\u2019s disease patients","volume":"114","author":"Quinti","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.3233\/JHD-230588_ref34","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/nprot.2012.116","article-title":"Directed differentiation of humanpluripotent stem cells to cerebral cortex neurons and neuralnetworks","volume":"7","author":"Shi","year":"2012","journal-title":"Nat Protoc"},{"issue":"19","key":"10.3233\/JHD-230588_ref35","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.3233\/JHD-230588_ref36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.3233\/JHD-230588_ref37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.3233\/JHD-230588_ref38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JHD-140111","article-title":"The co-occurrence of Alzheimer\u2019s disease and Huntington\u2019s disease: A neuropathological study of 15 elderly Huntington\u2019s disease subjects","volume":"3","author":"Davis","year":"2014","journal-title":"J Huntingtons Dis"},{"issue":"7","key":"10.3233\/JHD-230588_ref39","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/mds.22204","article-title":"Association of corticobasal degeneration and Huntington\u2019s disease: Can Tau aggregates protect Huntingtin toxicity?","volume":"24","author":"Caparros-Lefebvre","year":"2009","journal-title":"Mov Disord"},{"issue":"5","key":"10.3233\/JHD-230588_ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0250-2","article-title":"Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.3233\/JHD-230588_ref41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2478\/s13380-012-0032-y","article-title":"Soluble forms of tau are toxic in Alzheimer\u2019s disease","volume":"3","author":"Kopeikina","year":"2012","journal-title":"Transl Neurosci"},{"key":"10.3233\/JHD-230588_ref42","doi-asserted-by":"crossref","first-page":"105293","DOI":"10.1016\/j.nbd.2021.105293","article-title":"Super-resolution imaging reveals extrastriatal synaptic dysfunction in presymptomatic Huntington disease mice","volume":"152","author":"Ravalia","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-230588_ref43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pneurobio.2017.03.008","article-title":"Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington\u2019s disease","volume":"153","author":"Tyebji","year":"2017","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JHD-230588_ref44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington\u2019s disease: Time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"issue":"2","key":"10.3233\/JHD-230588_ref45","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"issue":"10","key":"10.3233\/JHD-230588_ref46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington\u2019s disease: A synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.3233\/JHD-230588_ref47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/hmg\/ddu421","article-title":"Mutant huntingtin alters Tau phosphorylation and subcellular distribution","volume":"24","author":"Blum","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.3233\/JHD-230588_ref48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/hmg\/ddu456","article-title":"Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington\u2019s disease","volume":"24","author":"Gratuze","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-230588_ref49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-981-32-9358-8_29","article-title":"Cerebrospinal fluid and plasma tau as a biomarker for brain tauopathy","volume":"1184","author":"Shoji","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.3233\/JHD-230588_ref50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2217\/17520363.2.4.363","article-title":"Tau as a biomarker of neurodegenerative diseases","volume":"2","author":"Schraen-Maschke","year":"2008","journal-title":"Biomark Med"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-230588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:56:18Z","timestamp":1777452978000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-230588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":50,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jhd-230588","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]}}}